Limaprost
| Title | Journal |
|---|---|
| Discontinued cardiovascular drugs in 2013 and 2014. | Expert opinion on investigational drugs 20150101 |
| Limaprost reduces motor disturbances by increasing the production of insulin-like growth factor I in rats subjected to spinal cord injury. | Translational research : the journal of laboratory and clinical medicine 20101101 |
| Lumbar spinal stenosis: a brief review of the nonsurgical management. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20100701 |
| Pharmacokinetic characteristics of a vasodilatory and antiplatelet agent, limaprost alfadex, in the healthy Korean volunteers. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100601 |
| Limaprost alfadex improves myelopathy symptoms in patients with cervical spinal canal stenosis. | Spine 20090315 |
| Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. | Journal of pharmacological sciences 20090301 |
| The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. | Spine 20090115 |
| Resorption of thoracic disc herniation. Report of 2 cases. | Journal of neurosurgery. Spine 20080301 |
| Improved stability of Opalmon tablets under humid conditions IV: effect of polysaccharides and disintegrants on the stability and dissolution property of Opalmon tablets. | Chemical & pharmaceutical bulletin 20080101 |
| Stabilization mechanism of limaprost in solid dosage form. | International journal of pharmaceutics 20070629 |
| Ultra sensitive determination of limaprost, a prostaglandin E1 analogue, in human plasma using on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601 |
| Limaprost. | Drugs 20070101 |
| Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster. | Pain medicine (Malden, Mass.) 20070101 |
| Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. | European journal of pharmacology 20050725 |
| Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice. | European journal of pharmacology 20040714 |
| Activation of extracellular signal-regulated protein kinase in dorsal horn neurons in the rat neuropathic intermittent claudication model. | Pain 20040501 |
| Mechanisms of prostaglandin E1-induced relaxation in penile resistance arteries. | The Journal of urology 20040201 |
| Effects of orally administered OP-1206 alpha-CD with loxoprofen-Na on walking dysfunction in the rat neuropathic intermittent claudication model. | Prostaglandins, leukotrienes, and essential fatty acids 20031001 |
| Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol. | Prostaglandins & other lipid mediators 20030701 |
| Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue. | Cancer chemotherapy and pharmacology 20030301 |
| Bilateral scalp necrosis with giant cell arteritis. | The Journal of dermatology 20030301 |
| Correlation between methotrexate-induced intestinal damage and decrease in polyamine content. | Life sciences 20021227 |
| A synthetic analog of prostaglandin E(1) prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats. | Life sciences 20020719 |
| The effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model. | Anesthesia and analgesia 20020601 |
| Effect of a synthetic analog of prostaglandin E1 on the intestinal mucosa of methotrexate-treated rats. | Anticancer research 20010101 |